Found 411 results
Bournazos S, Klein F, Pietzsch J, Seaman MS, Nussenzweig MC, Ravetch JV.  2014.  Broadly Neutralizing Anti-HIV-1 Antibodies Require Fc Effector Functions for In Vivo Activity.. Cell. 158(6):1243-53.
Falkowska E, Le KM, Ramos A, Doores KJ, Lee J H, Blattner C, Ramirez A, Derking R, van Gils MJ, Liang C-H et al..  2014.  Broadly Neutralizing HIV Antibodies Define a Glycan-Dependent Epitope on the Prefusion Conformation of gp41 on Cleaved Envelope Trimers.. Immunity. 40(5):657-68.
Guttman M, Garcia NK, Cupo A, Matsui T, Julien J-P, Sanders RW, Wilson IA, Moore JP, Lee KK.  2014.  CD4-induced activation in a soluble HIV-1 Env trimer.. Structure. 22(7):974-84.
Madani N, Princiotto AM, Schön A, LaLonde J, Feng Y, Freire E, Park J, Courter JR, Jones DM, Robinson J et al..  2014.  CD4-mimetic small molecules sensitize human immunodeficiency virus to vaccine-elicited antibodies.. J Virol. 88(12):6542-55.
Gitlin AD, Shulman, iv Z, Nussenzweig MC.  2014.  Clonal selection in the germinal centre by regulated proliferation and hypermutation.. Nature. 509(7502):637-40.
Azoitei ML, Ban YA, Kalyuzhny O, Guenaga J, Schroeter A, Porter J, Wyatt R, Schief WR.  2014.  Computational design of protein antigens that interact with the CDR H3 loop of HIV broadly neutralizing antibody 2F5.. Proteins. 82(10):2770-82.
Gao F, Bonsignori M, Liao H-X, Kumar A, Xia S-M, Lu X, Cai F, Hwang K-K, Song H, Zhou T et al..  2014.  Cooperation of B Cell Lineages in Induction of HIV-1-Broadly Neutralizing Antibodies.. Cell. 158(3):481-91.
Doria-Rose NA, Schramm CA, Gorman J, Moore PL, Bhiman JN, Dekosky BJ, Ernandes MJ, Georgiev IS, Kim HJ, Pancera M et al..  2014.  Developmental pathway for potent V1V2-directed HIV-neutralizing antibodies.. Nature. 509(7498):55-62.
Porichis F, Hart MG, Zupkosky J, Barblu L, Kwon DS, McMullen A, Brennan T, Ahmed R, Freeman GJ, Kavanagh DG et al..  2014.  Differential impact of PD-1 and/or IL-10 blockade on HIV-1-specific CD4 T cell and antigen-presenting cell functions.. J Virol.
Morou A, Palmer BE, Kaufmann DE.  2014.  Distinctive features of CD4+ T cell dysfunction in chronic viral infections.. Curr Opin HIV AIDS. 9(5):446-51.
Shulman, iv Z, Gitlin AD, Weinstein JS, Lainez B, Esplugues E, Flavell RA, Craft JE, Nussenzweig MC.  2014.  Dynamic signaling by T follicular helper cells during germinal center B cell selection.. Science. 345(6200):1058-62.
Seddiki N, Kaufmann DE.  2014.  Editorial overview: cell dysfunction and exhaustion in HIV infection.. Curr Opin HIV AIDS. 9(5):437-8.
Klein F, Nogueira L, Nishimura Y, Phad G, West AP, Halper-Stromberg A, Horwitz JA, Gazumyan A, Liu C, Eisenreich TR et al..  2014.  Enhanced HIV-1 immunotherapy by commonly arising antibodies that target virus escape variants.. J Exp Med. 211(12):2361-72.
Bates JT, Keefer CJ, Slaughter JC, Kulp DW, Schief WR, Crowe JE.  2014.  Escape from neutralization by the respiratory syncytial virus-specific neutralizing monoclonal antibody palivizumab is driven by changes in on-rate of binding to the fusion protein.. Virology. 454-455:139-44.
Porichis F, Hart MG, Griesbeck M, Everett HL, Hassan M, Baxter AE, Lindqvist M, Miller SM, Soghoian DZ, Kavanagh DG et al..  2014.  High-throughput detection of miRNAs and gene-specific mRNA at the single-cell level by flow cytometry.. Nat Commun. 5:5641.
Forsell MNE, McKee K, Feng Y, Mascola JR, Wyatt RT.  2014.  HIV-1 envelope glycoprotein trimer immunogenicity elicited in the presence of human CD4 alters the neutralization profile.. AIDS Res Hum Retroviruses. 30(11):1089-98.
Navis M, Tran K, Bale S, Phad GE, Guenaga J, Wilson R, Soldemo M, McKee K, Sundling C, Mascola J et al..  2014.  HIV-1 receptor binding site-directed antibodies using a VH1-2 gene segment orthologue are activated by Env trimer immunization.. PLoS Pathog. 10(8):e1004337.
Ingale J, Tran K, Kong L, Dey B, McKee K, Schief W, Kwong PD, Mascola JR, Wyatt RT.  2014.  Hyperglycosylated stable core immunogens designed to present the CD4 binding site are preferentially recognized by broadly neutralizing antibodies.. J Virol. 88(24):14002-16.
Barouch DH, Deeks SG.  2014.  Immunologic strategies for HIV-1 remission and eradication.. Science. 345(6193):169-74.
Li Q, Zeng M, Duan L, Voss JE, Smith AJ, Pambuccian S, Shang L, Wietgrefe S, Southern PJ, Reilly CS et al..  2014.  Live simian immunodeficiency virus vaccine correlate of protection: local antibody production and concentration on the path of virus entry.. J Immunol. 193(6):3113-25.
Li S, Rouphael N, Duraisingham S, Romero-Steiner S, Presnell S, Davis C, Schmidt DS, Johnson SE, Milton A, Rajam G et al..  2014.  Molecular signatures of antibody responses derived from a systems biology study of five human vaccines.. Nat Immunol. 15(2):195-204.
Shingai M, Donau OK, Plishka RJ, Buckler-White A, Mascola JR, Nabel GJ, Nason MC, Montefiori D, Moldt B, Poignard P et al..  2014.  Passive transfer of modest titers of potent and broadly neutralizing anti-HIV monoclonal antibodies block SHIV infection in macaques.. J Exp Med. 211(10):2061-74.
Trist HM, Tan PSzee, Wines BD, Ramsland PA, Orlowski E, Stubbs J, Gardiner EE, Pietersz GA, Kent SJ, Stratov I et al..  2014.  Polymorphisms and interspecies differences of the activating and inhibitory FcγRII of Macaca nemestrina influence the binding of human IgG subclasses.. J Immunol. 192(2):792-803.
Xie J, Yea K, Zhang H, Moldt B, He L, Zhu J, Lerner RA.  2014.  Prevention of cell death by antibodies selected from intracellular combinatorial libraries.. Chem Biol. 21(2):274-83.
Sok D, Doores KJ, Briney B, Le KM, Saye-Francisco KL, Ramos A, Kulp DW, Julien J-P, Menis S, Wickramasinghe L et al..  2014.  Promiscuous Glycan Site Recognition by Antibodies to the High-Mannose Patch of gp120 Broadens Neutralization of HIV.. Sci Transl Med. 6(236):236ra63.